Showing results (181-190 of 366) with videos related to
Sort By:
Pageof 37
Clinical and Experimental Rheumatology|November 9, 2005
The consequences of rheumatoid arthritis: quality of life measures in the individual patientL Pollard, E H Choy, D L ScottJournal of Pharmaceutical and Biomedical Analysis|January 1, 1989
Determination of cytidine deaminase activity in synovial fluid by HPLCK E Herbert, D L Scott, D PerrettEuropean Journal of Clinical Pharmacology|January 1, 1982
The pharmacokinetics of diclofenac sodium in patients with active rheumatoid diseaseP R Crook, J V Willis, M J Kendall, et al.British Journal of Rheumatology|August 1, 1996
Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathyA M Salih, N B Nixon, R M Gagan, et al.The Journal of Rheumatology|March 15, 2001
HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritisD L Mattey, P T Dawes, M A Gonzalez-Gay, et al.Rheumatology (Oxford, England)|May 20, 1999
The therapeutic response to D-penicillamine in rheumatoid arthritis: influence of glutathione S-transferase polymorphismsM A Layton, P W Jones, J E Alldersea, et al.Rheumatology (Oxford, England)|April 20, 2001
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activityJ C Chehata, A B Hassell, S A Clarke, et al.Rheumatology International|January 1, 1983
The use of 'alternative treatments' by patients with rheumatoid arthritisG R Struthers, D L Scott, D G ScottAnnals of the Rheumatic Diseases|September 1, 1990
Lymphoedema of the limbs as an extra-articular feature of rheumatoid arthritisJ E Dacre, D L Scott, E C HuskissonClinical Rheumatology|December 1, 1989
An assessment of tenoxicam, a nonsteroidal anti-inflammatory drug of long half-life, in patients with impaired renal function suffering from osteoarthritis or rheumatoid arthritisH A Bird, A K Clarke, P D Fowler, et al.Pageof 37